Tesamorelin (20 mg Vial)

Complete dosage protocol and reconstitution guide for Tesamorelin (20 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Tesamorelin (20 mg Vial)

CAT No:

CAS No:

Synonyms/Alias:Tesamorelin

M.F/Formula:

M.W/Mr.:

Purity:Specification by inquiry

Custom Peptide Support
  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Complete dosage protocol and reconstitution guide for Tesamorelin (20 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water per 20 mg vial → ~6.67 mg/mL concentration.

Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol).

Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.

Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F) ; reconstituted: refrigerate and use within 7 days with bacteriostatic water.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [10] . Rotate injection sites (abdomen at least 2 inches from navel, thighs, upper arms) to reduce local irritation [6] [10] . Inject slowly; wait a few seconds before withdrawing the needle. Monitor IGF-1 levels periodically due to potent GH stimulation; observe blood glucose in diabetic patients [9] . Document daily dose and site rotation to maintain consistency.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Source URL
https://peptide.cn.com/single-peptide-dosages/tesamorelin-20-mg-vial-dosage-protocol
Week 1
Daily Dose (mg / mcg): 1 mg / 1000 mcg | Units (per injection) (mL): 15 units (0.15 mL)
Weeks 2–12+
Daily Dose (mg / mcg): 2 mg / 2000 mcg | Units (per injection) (mL): 30 units (0.30 mL)
Long-term Storage Conditions
Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F) ; reconstituted: refrigerate and use within 7 days with bacteriostatic water.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Tesamorelin, 20 mg each): 8 weeks ≈ 6 vials (105 mg total)

12 weeks ≈ 9 vials (161 mg total)

16 weeks ≈ 11 vials (217 mg total)

Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (6 vials): 18 mL → 2 × 10 mL bottles

12 weeks (9 vials): 27 mL → 3 × 10 mL bottles

16 weeks (11 vials): 33 mL → 4 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes

Product Gallery
Quick Inquiry
Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsApp Mia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China